Physiological transport systems

Physiological transport systems refer to the collective mechanisms and pathways responsible for the movement of ions, nutrients, and metabolic products across biological membranes and between body compartments (ChEMBL, 2024). In a pharmacological context, this term is often used as a placeholder for drugs whose therapeutic effects are mediated by altering these transport processes, even when the specific molecular target—such as a particular solute carrier (SLC) transporter or ion channel—has not been definitively identified (EMBL-EBI, 2024). Examples include osmotic diuretics and certain laxatives that function by creating concentration gradients rather than binding to a specific protein pocket (PubChem, 2024). Because this category encompasses a wide array of uncharacterized or multi-component processes, it does not represent a single therapeutic target for drug design. Instead, it highlights a functional outcome observed in vivo or in complex cellular assays. For biotech analysts, identifying a drug within this category suggests a phenotypic discovery origin and underscores the necessity for target deconvolution to improve molecular specificity and reduce potential off-target risks (PubMed, 2024). This classification serves as a reminder of the gaps in current molecular mapping for established physiological effects.

Other names

Unknown/physiological transport systemsUnspecified transport systemsPhysiological transport mechanism

Non-specific modulation of osmotic gradients or uncharacterized membrane transport pathways.